Summary
A surge in drug research in China has driven the cost of a laboratory monkey to about 140,000 yuan (US$20,260), a sum that exceeds the countrys average annual wage.
Official government procurement records showed that prices had doubled in the last five years for such monkeys, which are widely used…
Source: South China Morning Post

AI News Q&A (Free Content)
Q1: What factors have contributed to the increase in the price of laboratory monkeys in China?
A1: The surge in drug research in China, driven by the country's burgeoning biotech industry, has significantly increased the demand for laboratory monkeys. This heightened demand has led to a climb in their prices to about 140,000 yuan (US$20,260), which is more than the average annual wage in the country. The increase in prices reflects the doubling of costs over the last five years, as indicated by official government procurement records.
Q2: How does the pharmaceutical industry impact the demand for laboratory monkeys?
A2: The pharmaceutical industry relies heavily on animal testing, including the use of laboratory monkeys, to discover, develop, and produce medications. The global pharmaceutical market, valued at approximately US$1.48 trillion in 2022, shows steady growth, necessitating increased research and testing. This has spurred demand for laboratory monkeys as crucial subjects in biomedical research, particularly for developing new drugs and testing their efficacy and safety.
Q3: What ethical concerns are associated with the use of laboratory monkeys in biomedical research?
A3: The use of laboratory monkeys in biomedical research raises significant ethical concerns, including the welfare and humane treatment of these animals. Ethical debates focus on the necessity and justification of using primates for testing, considering the potential for distress and suffering. Efforts to replace, reduce, and refine animal testing, known as the 'Three Rs,' aim to address these concerns by promoting alternative methods and improving animal welfare standards.
Q4: What are some alternative methods being explored to reduce the reliance on laboratory monkeys in research?
A4: Researchers are exploring various alternative methods to reduce reliance on laboratory monkeys, including advanced in vitro techniques, computer modeling, and the use of lower organisms like zebrafish and fruit flies. These methods aim to replicate human biological processes more ethically and cost-effectively. Advances in biotechnology and computational biology continue to enhance the accuracy and applicability of these alternatives, potentially reducing the need for primate testing.
Q5: How has China's biotech boom influenced global trends in biomedical research?
A5: China's biotech boom has positioned the country as a significant player in global biomedical research. With substantial investments in research and development and a growing domestic market, China has accelerated innovation in drug discovery and development. This has prompted increased collaboration and competition in the global biotech sector, influencing trends such as precision medicine, genomics, and personalized therapies.
Q6: What are the economic implications of rising laboratory monkey prices for research institutions?
A6: The rising prices of laboratory monkeys have significant economic implications for research institutions, increasing the costs of conducting biomedical research. Institutions may need to allocate more funding to animal procurement, potentially affecting budgets and limiting the scope of research projects. This financial strain may prompt institutions to seek alternative research methods or prioritize projects with the highest potential for breakthrough discoveries.
Q7: What role does regulatory oversight play in the procurement and use of laboratory monkeys in research?
A7: Regulatory oversight plays a crucial role in the procurement and use of laboratory monkeys, ensuring ethical standards and welfare considerations are met. Regulations govern aspects such as sourcing, housing, care, and use of primates in research. Compliance with these regulations is essential for maintaining research integrity and public trust. Regulatory bodies also promote the development and adoption of alternative testing methods to reduce animal use.
References:
- South China Morning Post
- Wikipedia - Pharmaceutical industry





